Search by Drug Name or NDC
NDC 00832-0742-60 Propafenone Hydrochloride 425 mg/1 Details
Propafenone Hydrochloride 425 mg/1
Propafenone Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Upsher-Smith Laboratories, LLC. The primary component is PROPAFENONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Propafenone is used to treat arrhythmia (irregular heartbeat) and to maintain a normal heart rate. Propafenone is in a class of medications called antiarrhythmics. It works by acting on the heart muscle to improve the heart's rhythm.
Related Packages: 00832-0742-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Propafenone
Product Information
| NDC | 00832-0742 |
|---|---|
| Product ID | 0832-0742_38dfeb26-ff08-45c2-9f6f-57be81c204ac |
| Associated GPIs | 35300050006940 |
| GCN Sequence Number | 053541 |
| GCN Sequence Number Description | propafenone HCl CAP ER 12H 425 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 21059 |
| HICL Sequence Number | 004833 |
| HICL Sequence Number Description | PROPAFENONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Propafenone Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Propafenone Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 425 |
| Active Ingredient Units | mg/1 |
| Substance Name | PROPAFENONE HYDROCHLORIDE |
| Labeler Name | Upsher-Smith Laboratories, LLC |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212744 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00832-0742-60 (00832074260)
| NDC Package Code | 0832-0742-60 |
|---|---|
| Billing NDC | 00832074260 |
| Package | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0742-60) |
| Marketing Start Date | 2020-06-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |